Consolidated Statement of Cash Flows

IR

Consolidated Statement of Cash Flows

(Million yen)

 
FY2022
(as of December 31,
2022)
FY2023
(as of December 31,
2023)
Cash flows from operating activities  
 
Profit before income taxes 9,922 9,073
Depreciation 228 363
Amortization of goodwill 164 385
Increase (decrease) in allowance
for doubtful accounts 
31 4
Increase (decrease) in provision for
bonuses
125 (132)
Interest and dividend income (3) (5)
Interest expenses 7 7
Share of loss (profit) of entities
accounted for using equity method
(64) (56)
Gain on sale of non-current assets (66)
Loss on retirement of non-current assets 25 24
Loss (gain) on sale of investment
securities
(69) (346)
Loss on COVID-19 22
Decrease (increase) in trade receivables (1,771) 961
Decrease (increase) in accounts receivable-other (8) (855)
Increase (decrease) in trade payables 310 (204)
Increase (decrease) in
accrued expenses
330 (33)
Increase (decrease) in
accrued consumption taxes
395 (857)
Increase (decrease) in accrued
enterprise taxes
37 (49)
Increase (decrease) in
retirement benefit liability
68 78
Other, net 197 1,062
Subtotal 9,946 9,354
Interest and dividends 
received
3 5
Interest 
paid
(7) (7)
Payment of loss on COVID-19 (21)
Income taxes paid (3,126) (4,208)
Income taxes refund 1 18
Net cash provided by (used in) operating
activities
6,796 5,163

(Million yen)

 
FY2022
(as of December 31,
2022)
FY2023
(as of December 31,
2023)
Cash flows from investing activities  
 
Proceeds from withdrawal of time deposits 1,158
Purchase of property,
plant and equipment
(103) (116)
Proceeds from sale of property, plant and equipment 266
Purchase of intangible assets (181) (183)
Purchase of investment securities (13) (98)
Proceeds from sales of investment
securities
186 346
Purchase of shares of subsidiaries
resulting in change in scope of
consolidation
(844) (7,511)
Additional purchase of investments in consolidated subsidiaries (450)
Proceeds from collection of
loans receivable
6 27
Other, net (9) 196
Net cash provided by (used in) investing
activities
(958) (6,366)
Cash flows from financing activities  
 
Repayments of long-term borrowings (46) (604)
Purchase of treasury shares (907) (2,026)
Dividends paid (1,667) (2,295)
Other, net (2) (30)
Net cash provided by (used in) financing
activities
(2,622) (4,954)
Effect of exchange rate change on cash and cash equivalents 0
Net increase (decrease)
in cash and cash equivalents
3,216 (6,158)
Cash and cash equivalents
at beginning of period
17,410 20,626
Cash and cash equivalents
at end of period
20,626 14,468

ARCHIVE